Allyx Therapeutics is developing an oral drug that demonstrates reversal of learning and memory deficits due to Alzheimer’s disease.
Location: United States, New York
Employees: 1-10
Founded date: 2018
Investors 3
| Date | Name | Website |
| 26.05.2021 | Life Scien... | lifescienc... |
| - | Connecticu... | ctinnovati... |
| 28.10.2021 | Harbor Str... | harborstre... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 13.01.2021 | Allyx Therapeutics Announces License For The Treatment of Co... | NEW HAVEN, Conn. (PRWEB) January 13, 2021 Today, Allyx Therapeutics announced the completion of a l... | prweb.com/... |